Business news, market intelligence, and global industry analysis.
The Latest

Alkem Labs clears UK MHRA inspection of bioequivalence center in Taloja

bySrinath
May 14, 2022
Total
0
Shares
0
0
0

Alkem Laboratories Limited (Alkem Labs) revealed that it has cleared an online inspection held by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its bioequivalence center in Taloja, Maharashtra.

According to the Indian pharma company, the inspection of the bioequivalence facility in Taloja was carried out from 31 January 2022 and 4 February 2022 and 8 February 2022 to 10 February 2022.

Alkem Laboratories said that a Good Clinical Practice (GCP) Inspection Statement released on 12 May 2022 showed that no critical or major observations were identified and the inspection has been closed.

Recently, the Indian pharma company had cleared inspection at its manufacturing facility in Daman, which was held by Instituto de Salud Pública de Chile (ISP Chile).

Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

See also  Zydus Lifesciences gets FDA approval for Estradiol Transdermal System
Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735

ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), which is being developed by its subsidiary – Janssen Pharmaceutical Companies. The US healthcare giant said that the ENSEMBLE vaccine trial has been initiated following positive interim results from its […]
bypharmanewsdaily
Read More

Icosavax, a new vaccine development company, launched in Seattle

Icosavax, a new pharma company, focused on developing vaccines against infectious diseases, has been launched in Seattle, Washington. The vaccine development company is backed by $51 million capital raised through a Series A financing round led by Qiming Venture Partners USA. Other investors in Icosavax are Sanofi Ventures, Adams Street Partners, and NanoDimension, alongside continuing […]

The post Icosavax, a new vaccine development company, launched in Seattle appeared first on PharmaNewsDaily.com.

bypharmanewsdaily